$ASEP peptide tech could save thousands of lives ASEP Medical Holdings Inc. is a biotech company that recently went public on the CSE under the ticker $ASEP.C
$ASEP is in the process of commercializing peptide and anti-sepsis technology.
Serious bacterial infections are the cause of hundreds of thousands of deaths (source: https://www.gardp.org/programme/serious-bacterial-infections/), However, $ASEP's peptide tech can help antibiotics attack bacteria more directly by preventing bacteria's biofilm growth.
Their anti-sepsis technology seems even more promising to me. Sepsis kills over 10 million people yearly and many of these deaths are due to the sepsis going undetected for too long.
$ASEP's sepsis detection kits detect sepsis in just an hour which is 23 hours sooner than industry-standard tests.
These kits are currently undergoing worldwide clinical trials which is a major step towards $ASEP commercializing them.
Because of the life-saving power of $ASEP's peptides and sepsis kits, I think that the current share price ( $0.82/share ) is a complete steal.